WFA of San Diego’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.7K Hold
120
0.01% 264
2025
Q4
$14.7K Hold
120
0.01% 290
2025
Q3
$13.3K Sell
120
-30
-20% -$3.41K 0.01% 306
2025
Q2
$16.6K Buy
+150
New +$16K 0.01% 284
2024
Q3
$12.6K Hold
150
0.01% 268
2024
Q2
$10.3K Buy
+150
New +$10K 0.01% 279
2023
Q3
$11.2K Hold
150
0.01% 273
2023
Q2
$11.6K Buy
+150
New +$12K 0.01% 271
2023
Q1
Sell
-1,510
Closed -$130K 193
2022
Q4
$130K Buy
+1,510
New +$120K 0.1% 115
2022
Q3
Sell
-1,510
Closed -$93K 192
2022
Q2
$93K Buy
+1,510
New +$93.5K 0.08% 119
2022
Q1
Sell
-1,565
Closed -$114K 111
2021
Q4
$114K Hold
1,565
0.07% 158
2021
Q3
$109K Buy
+1,565
New +$110K 0.08% 138
2020
Q3
Sell
-3,496
Closed -$219K 135
2020
Q2
$219K Buy
+3,496
New +$268K 0.05% 238

Other funds holding GILD

WFA of San Diego's GILD Position: Q1 2026 in Review

WFA of San Diego held its Gilead Sciences (GILD) position steady in Q1 2026 at 120 shares worth $16.7K. The position accounts for 0.01% of the portfolio, ranked #264.

WFA of San Diego first reported a position in GILD in Q2 2020 and has held it in 13 quarters since. The position peaked at $219K in Q2 2020. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • WFA of San Diego held 120 shares of Gilead Sciences worth $16.7K as of Q1 2026.
  • WFA of San Diego left its Gilead Sciences share count unchanged in Q1 2026.
  • Gilead Sciences made up 0.01% of WFA of San Diego's portfolio in Q1 2026, its #264 holding.
  • WFA of San Diego first reported a position in Gilead Sciences in Q2 2020 and has held it in 13 quarters since.
  • WFA of San Diego's Gilead Sciences position peaked at $219K in Q2 2020.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on WFA of San Diego's 13F filing for Q1 2026, filed 11 May 2026.